Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)
CUSIP: 19188J409
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 13,831,528
- Total 13F shares
- 683,341
- Share change
- -21,109
- Total reported value
- $1,173,672
- Price per share
- $1.72
- Number of holders
- 16
- Value change
- -$35,542
- Number of buys
- 5
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 19188J409?
CUSIP 19188J409 identifies COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 19188J409:
Top shareholders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
275,656
|
$515,477 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.91%
|
126,228
|
$236,000 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.54%
|
74,063
|
$138,498 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.52%
|
72,179
|
$134,975 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
60,432
|
$113,031 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.32%
|
44,453
|
$83,127 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
24,443
|
$45,708 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
12,207
|
$22,828 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
9,028
|
$16,882 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
3,348
|
$6,261 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
1,744
|
$3,261 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
187
|
$350 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
89
|
$166 | — | 30 Sep 2023 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
84
|
$157 | — | 30 Sep 2023 | |
| NVWM, LLC |
13F
|
Company |
0%
|
84
|
$157 | — | 30 Sep 2023 |
Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q4 2023
As of 31 Dec 2023,
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
683,341 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, NORTHERN TRUST CORP, BANK OF AMERICA CORP /DE/, and Tower Research Capital LLC (TRC).
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
15
Q4 2023 holders
16
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.